Watchlist Price Alert

Kairos Pharma Ltd. (KAPA)

AMEX: KAPA · Real-Time Price · USD

0.54

0.02 (3.85%)

At close: Jun 16, 2025, 2:45 PM

Kairos Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022
Cash & Equivalents	3.62M	1.27M	3.22M	21K	40K	93K	99K	232K	357K	437K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.71M	1.38M	n/a	690K	571K	482K	410K	258K	129K	57K
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.43M	38K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	6.05M	4.17M	4.74M	38K	59K	101K	116K	258K	374K	437K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	182K	222K	262K	302K	342K	382K	422K	462K	502K	542K
Total Long-Term Assets	1.89M	1.6M	262K	992K	913K	864K	832K	720K	631K	599K
Total Assets	7.94M	5.77M	5M	1.03M	972K	965K	948K	978K	1M	1.04M
Account Payables	n/a	992K	1.53M	1.92M	1.89M	2.4M	1.41M	1.93M	1.73M	1.63M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	142K	n/a	n/a	n/a	n/a	4K	4K	4K
Other Current Liabilities	805K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	805K	992K	1.67M	1.92M	1.89M	2.4M	1.41M	1.94M	1.74M	1.63M
Long-Term Debt	n/a	n/a	n/a	n/a	657K	638K	n/a	602K	592K	582K
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	657K	638K	n/a	602K	592K	582K
Total Liabilities	805K	992K	1.67M	1.92M	1.89M	3.04M	1.41M	2.54M	2.33M	2.21M
Total Debt	n/a	n/a	142K	n/a	n/a	638K	n/a	606K	596K	586K
Common Stock	16K	14K	13K	11K	11K	11K	11K	103K	103K	10K
Retained Earnings	-10.08M	-8.81M	-7.83M	-6.79M	-6.62M	-6.21M	-5.09M	-4.78M	-4.55M	-4.4M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	0.00	n/a
Shareholders Equity	7.13M	4.78M	3.33M	-885K	-919K	-2.08M	-463K	-1.56M	-1.32M	-1.18M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a